Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00453908
Status:
TERMINATED
Last Update Posted:
2007-08-20
First Post:
2007-03-28
Brief Title:
Alfuzosin Versus Placebo in Acute Urinary Retention
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Does Alfuzosin OD vs Placebo in Male Patients Facilitate Spontaneous Voiding During Clean Intermittent Self-Catheterization Following Acute Urinary Retention
Status:
TERMINATED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The study was early terminated due to slow and difficult recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALF-RIK
Brief Summary:
The primary objective of the study is to investigate if 14 days of treatment with Alfuzosin compared to placebo will increase the number of patients with satisfying spontaneous voiding after acute urinary retention treated with Clean Self-Catheterization
Furthermore is investigated the safety of the medical treatment and self-catheterization
Furthermore is investigated the safety of the medical treatment and self-catheterization
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None